Dolutegravir dosing with rifampicin Reply

被引：0

作者：

Maartens, Gary ^{[1
,2
]}

Griesel, Rulan ^{[1
,2
]}

机构：

[1] Univ Cape Town, Fac Hlth Sci, Dept Med, Div Clin Pharmacol, ZA-7935 Cape Town, South Africa

[2] Univ Cape Town, Inst Infect Dis & Mol Med, Wellcome Ctr Infect Dis Res Africa, Dept Med, Cape Town, South Africa

来源：

LANCET HIV | 2023年 / 10卷 / 10期

关键词：

D O I：

10.1016/S2352-3018(23)00230-8

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：E636 / E636

页数：1

共 4 条

[1] Standard-dose versus double-dose dolutegravir in HIV- associated tuberculosis in South Africa (RADIANT-TB) : a phase 2, non-comparative, randomised controlled trial [J].

Griesel, Rulan ;

Zhao, Ying ;

Simmons, Bryony ;

Omar, Zaayid ;

Wiesner, Lubbe ;

Keene, Claire M. ;

Hill, Andrew M. ;

Meintjes, Graeme ;

Maartens, Gary .

LANCET HIV, 2023, 10 (07) :E433-E441

[2] Population Pharmacokinetic Model and Alternative Dosing Regimens for Dolutegravir Coadministered with Rifampicin [J].

Kawuma, Aida N. ;

Wasmann, Roeland E. ;

Dooley, Kelly E. ;

Boffito, Marta ;

Maartens, Gary ;

Denti, Paolo .

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2022, 66 (06)

[3] Drug-drug interaction between rifabutin and dolutegravir: A population pharmacokinetic model [J].

Kawuma, Aida N. N. ;

Wasmann, Roeland E. E. ;

Dooley, Kelly E. E. ;

Maartens, Gary ;

Denti, Paolo .

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2023, 89 (03) :1216-1221

[4] Once daily dolutegravir (S/GSK1349572) in combination therapy in antiretroviral-naive adults with HIV: planned interim 48 week results from SPRING-1, a dose-ranging, randomised, phase 2b trial [J].

van Lunzen, Jan ;

Maggiolo, Franco ;

Arribas, Jose R. ;

Rakhmanova, Aza ;

Yeni, Patrick ;

Young, Benjamin ;

Rockstroh, Juergen K. ;

Almond, Steve ;

Song, Ivy ;

Brothers, Cindy ;

Min, Sherene .

LANCET INFECTIOUS DISEASES, 2012, 12 (02) :111-118

← 1 →